Industry News

We gather useful links to news on the thousands of companies listed in the directory either directly from the company or independently from authoritative publicly available sources e.g. industry newspapers, journals and websites. You can use this news database to search these links. Search either by the name of company or by country/place or key word or combination thereof.

Search Term

Save This Search | View as Grid | Order by Recently Added | Order by Company Name

  • Total Results: 1,070
  • Total Pages: 54

Fosun Pharma 12 Jul 2019


Fosun Pharma picks up GSK plant in China along with rights to make Epivir generic


Even as GlaxoSmithKline has opened its most advanced manufacturing site in Asia, it is selling an older plant in China to Shanghai Fosun Pharmaceutical. 

 Fosun Pharma announced that it has a deal with GSK to buy its Suzhou pharmaceutical factory in east China near Shanghai for ¥250 million ($36 million), reports. Fosun, among China’s largest drugmakers, said the plant produced revenue of  ¥656.1 million ($94.4 million) last year. 

Read more on this story »


Avara Shannon Pharmaceutical Services 12 Jul 2019


Avara Shannon Pharmaceutical Services Ltd was hopelessly insolvent.


A High Court judge has made orders winding up a Co Clare based pharmaceutical company that employs more than 110 people. Avara Shannon Pharmaceutical Services Ltd was hopelessly insolvent, was loss-making to the tune of €9.5m per year and is unable to pay its workers, the court was told.


View original story »


Amicus Therapeutics, Inc. 11 Jul 2019


Amicus Therapeutics and Catalent Biologics Enter Strategic Partnership for Gene Therapy Development and Manufacturing


Amicus Therapeutics, Inc.(NASDAQ:FOLD) has entered into a strategic manufacturing agreement with Paragon Gene Therapy, a unit of Catalent Biologics.


View original story »


Wasdell Group 10 Jul 2019


Operations commence at Wasdell Group’s EU headquarters


The Wasdell Group (Wasdell), a leading outsourcing partner for the pharmaceutical industry, has today announced its new state-of-the-art facility in Dundalk, Ireland has received its Manufacturer’s / Importation Authorisation licence (MIA) from the Health Products Regulatory Authority (HPRA).


View original story »


Raffles PharmaTech 09 Jul 2019


Raffles Pharmatech


From June 18 to 20, 2019, the CPHI Exhibition was held in Shanghai as scheduled. Pharmaceutical counterparts from all over the world gathered in Shanghai to talk about pharmaceuticals.


View original story »


WuXi Biologics 09 Jul 2019


WuXi Biologics to Expand Integrated Biologics Conjugation Solution Center to Include Commercial Manufacturing


WUXI, China, June 21, 2019 –WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that it planned to expand the new state-of-the-art integrated biologics conjugation solution center to include commercial manufacturing in Wuxi city, China.


View original story »


Novartis 03 Jul 2019


Novartis unloading sterile production facility to Lonza


Novartis, looking to the future, has been shedding some of its manufacturing operations from the past. Some from the recent past. 


View original story »


Actex Pharma Services 03 Jul 2019


Aurobindo gets warning letter over valsartan recall mess


India’s Aurobindo Pharma has been one of the culprits found manufacturing the high blood pressure medicine valsartan with high levels of impurities that carry a risk of cancer. Now the FDA has savaged it in a warning letter for missteps that paved the pathway to the mess. 


View original story »


Catalent Pharma Solutions 03 Jul 2019


Catalent Completes Acquisition Of Gene Therapy Leader Paragon


Catalent Completes Acquisition Of Gene Therapy Leader Paragon Bioservices, Inc. For $1.2 Billion


View original story »


Catalent Pharma Solutions 03 Jul 2019


Catalent snaps up Novavax production sites and 100 employees in $18M deal


Another deal has been struck in the rapidly evolving market for gene therapy manufacturing. Just two months after Catalent jumped big time into the gene therapy realm, it is adding a couple of small vaccine production sites and a 100 employees to its operation.  


View original story »


Abbvie 02 Jul 2019


AbbVie to buy Irish-headquartered Allergan in $63bn deal


Deal to be funded with debt and cash on balance sheet


View original story »


Fusion Antibodies plc 02 Jul 2019


Record second half revenues as pharma research group grows US business


Fusion Antibodies sees full year revenues dip 19%



View original story »


Venn Life Sciences 01 Jul 2019


Venn Life Sciences to pursue ‘build to sell’ plan after merger


Combined group to fall under Open Orphan name


View original story »


Carrick Therapeutics 01 Jul 2019


Carrick Therapeutics to establish operations in Boston


Move will involve transition of leadership from founder Elaine Sullivan to Tim Pearson


View original story »


Uniphar Group 17 Jun 2019


Uniphar to raise up to €150m in IPO


Irish pharmaceuticals wholesaler and retailer will list on stock markets in London and Dublin


View original story »


Pfizer 17 Jun 2019


Pfizer to Acquire Array BioPharma


NEW YORK & BOULDER, Colo.--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and Array BioPharma Inc. (NASDAQ: ARRY) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Array, a commercial stage biopharmaceutical company focused on the discovery, development and commercialization of targeted small…


Read more on this story »


Bristol Laboratories Ltd 13 Jun 2019


MHRA gives Bristol Labs the all-clear


The U.K. generic drug maker, whose partial suspension by European regulators in 2017 led to shortages of some drugs, has passed its latest Medicines and Healthcare products Regulatory Agency (MHRA) inspection.


View original story »


Actex Pharma Services 13 Jun 2019


FDA hammers yet another Aurobindo plant for flawed data integrity


View original story »


Actex Pharma Services 13 Jun 2019


Venn Life Sciences to pursue ‘build to sell’ plan after merger Combined group to fall under Open Orphan name


Venn unveiled full-year results for 2018 on Tuesday, which showed the company’s sales dropped to €14.3 million from €17.8 million for the previous year.


View original story »


Aalto Bio Reagents Ltd 13 Jun 2019


Dublin biotech company launches protein to detect virus


Aalto Bio Reagents’ protein will detect and diagnose Venezuela equine encephalitis


View original story »

  • Total Results: 1,070
  • Total Pages: 54

About Us

SURIMS is the new name for Actex Pharma Services which was a consultancy established in 2003, supporting companies in the identification, qualification and management of quality vendors and suppliers in ingredients and formulations.

The Pharmaceutical Services Directory supports the identification and on-boarding of quality suppliers and also incorporates software features that manage relationships between suppliers and their customers. These include the building and deployment of questionnaires and assessments, electronic signatures and sign-offs and project management between vendor/partner and customer.

Access to the features and software is available on a 'pay as you go' basis, or a customised version can be licensed for your company for its own supplier on-boarding and supplier management activities. Further information on our software services please contact Tel: +353 87 294 0436 or email


Get in Touch

The Pharmaceutical Services Directory


© 2019 Actex Pharma Services | All Rights Reserved.